Work

Safety, pharmacokinetics, and activity of EZN‐2208, a novel conjugate of polyethylene glycol and SN38, in patients with advanced malignancies

Year: 2012

Type: article

Study design: Clinical Trial

Source: Cancer

DOI: 10.1002/cncr.27647

Authors: Razelle Kurzrock, Sanjay Goel, Jennifer Wheler, David Hong, Siqing Fu, Keyvan Rezai, Sonia K. Morgan‐Linnell, Saik Urien, Sridhar Mani, Imran Chaudhary, Mohammed H. Ghalib, Aby Buchbinder, François Lokiec, Mary Mulcahy

Institutions: The University of Texas MD Anderson Cancer Center, Albert Einstein College of Medicine, Yeshiva University, Hôpital René Huguenin, Institut Curie, Enzon Pharmaceuticals (United States), Northwestern University

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1580885593

FWCI: 2.569

Cites: 19

Cited by: 50

Related to: 10